A hybrid Fc-fused human growth hormone, GX-H9, shows a potential for semi-monthly administration in both adult and pediatric growth hormone deficiencies.

H. Michael Keyoung

講演情報

APPES/JSPE ジョイントセッション（英語）

APPES/JSPE ジョイントセッション（英語） » Oral

Oral 4: Growth

2016年11月19日(土) 10:45 〜 11:45 第1会場 (Hall C)

Moderator: Junko Ito (The Head of Department of Pediatrics, Toranomon Hospital Tokyo), Melinda Atienza (Department of Pediatrics Faculty of Medicine and Surgery University of Santo Tomas Manila)

11:35 〜 11:45

[O4-6] A hybrid Fc-fused human growth hormone, GX-H9, shows a potential for semi-monthly administration in both adult and pediatric growth hormone deficiencies.

^○H. Michael Keyoung¹, Aryaev Mykola², Eun Jig Lee³, Jochen Schopohl⁴, Tae Kyung Kim¹, Young-Joo Ahn⁵, Jung-Won Woo¹, Woo Ick Jang⁵, Young-Chul Sung¹ (1.Genexine, Inc., 2.Department of pathology of the newborns and premature infants, Municipal Institution, 3.Department of Internal Medicine IV, Ludwig-Maximilians University Munich, 4.Endocrinology/ Internal Medicine, Yonsei University College of Medicine, 5.Handok, Inc.)

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードはプログラム抄録集に掲載しております。